Get the latest information on this new treatment so you can share important details with your patients.
This program will deepen your understanding of:
- Lecanemab approval data, mechanism of action, side effects & monitoring
- How to discuss cost & treatment demands for patients
- Identifying eligible candidates for treatment consideration
- How to prepare patients and expedite referrals
Presented by:
- Gad Marshall, MD – Director of Clinical Trials at the BWH Center for Alzheimer Research and Treatment (CART)
- Dorene Rentz, PsyD – Co-Director, Outreach, Recruitment & Engagement Core at MADRC, Co-Director of CART
- Christine Ritchie, MD, MSPH – Co-Director, Outreach, Recruitment & Engagement Core at MADRC
- Mike Erkkinen, MD – Director BWH Division of Cognitive & Behavioral Neurology
- John Dickson, MD, PhD – Neurologist, MGH Memory Disorders Division
- Art Canter – Research Participant at MADRC